{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T12:27:46Z","timestamp":1786883266624,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","award":["Charles Moore Research Bursary (O.J.McE.)"],"award-info":[{"award-number":["Charles Moore Research Bursary (O.J.McE.)"]}],"id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK089507 (C.H.G. and S.L.H.)"],"award-info":[{"award-number":["P30 DK089507 (C.H.G. and S.L.H.)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001450 (P.A.F.)"],"award-info":[{"award-number":["UL1 TR001450 (P.A.F.)"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["FLUME17AB0"],"award-info":[{"award-number":["FLUME17AB0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["WEST15A0"],"award-info":[{"award-number":["WEST15A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GOSS15A0"],"award-info":[{"award-number":["GOSS15A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["FLUME15A0"],"award-info":[{"award-number":["FLUME15A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["WEST17AB0"],"award-info":[{"award-number":["WEST17AB0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HELTSH15A0"],"award-info":[{"award-number":["HELTSH15A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["007084L124 \\u2013 McElvaney (O.J.McE.)"],"award-info":[{"award-number":["007084L124 \\u2013 McElvaney (O.J.McE.)"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SANDER17AB0"],"award-info":[{"award-number":["SANDER17AB0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SANDER14A0"],"award-info":[{"award-number":["SANDER14A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jcf.2026.07.010","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:37:04Z","timestamp":1785296224000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Forced vital capacity in pulmonary exacerbations of cystic fibrosis"],"prefix":"10.1016","author":[{"given":"Oliver J.","family":"McElvaney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya L.","family":"Heltshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don B.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen J.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra","family":"Fogarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Flume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.07.010_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1183\/09031936.00159111","article-title":"Effect of pulmonary exacerbations on long\u2013term lung function decline in cystic fibrosis","volume":"40","author":"Waters","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.07.010_bib0002","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"Sanders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2026.07.010_bib0003","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/thoraxjnl-2013-203262","article-title":"Pulmonary exacerbations as indicators of progression of lung disease in young children with CF","volume":"68","author":"Sanders","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2026.07.010_bib0004","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1164\/rccm.202102-0461OC","article-title":"A randomized clinical trial of antimicrobial duration for cystic fibrosis pulmonary exacerbation treatment","volume":"204","author":"Goss","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2026.07.010_bib0005","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1513\/AnnalsATS.202308-673OC","article-title":"Adjunctive systemic corticosteroids for pulmonary exacerbations of cystic fibrosis","volume":"21","author":"McElvaney","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2026.07.010_bib0006","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jcf.2023.06.012","article-title":"Impact of lumacaftor\/ivacaftor and tezacaftor\/ivacaftor on treatment response in pulmonary exacerbations of F508del\/F508del cystic fibrosis","volume":"22","author":"McElvaney","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.07.010_bib0007","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcf.2025.12.007","article-title":"Correlates of FEV(1) deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomes","volume":"25","author":"McElvaney","year":"2026","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.07.010_bib0008","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1152\/jappl.1967.22.3.395","article-title":"Resistance of central and peripheral airways measured by a retrograde catheter","volume":"22","author":"Macklem","year":"1967","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jcf.2026.07.010_bib0009","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cmpb.2007.03.009","article-title":"A model\u2013based method for flow limitation analysis in the heterogeneous human lung","volume":"89","author":"Polak","year":"2008","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.jcf.2026.07.010_bib0010","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM199204303261804","article-title":"Prediction of mortality in patients with cystic fibrosis","volume":"326","author":"Kerem","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.07.010_bib0011","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.athoracsur.2015.04.022","article-title":"Mortality risk and pulmonary function in adults with cystic fibrosis at time of wait listing for lung transplantation","volume":"100","author":"Hayes","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jcf.2026.07.010_bib0012","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The pulmozyme study group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.07.010_bib0013","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM199203193261207","article-title":"A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis","volume":"326","author":"Hubbard","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.07.010_bib0014","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: cystic fibrosis foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.07.010_bib0015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1055\/s-0039-1697975","article-title":"Acute pulmonary exacerbations in cystic fibrosis","volume":"40","author":"Goss","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2026.07.010_bib0016","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1152\/jappl.1963.18.2.295","article-title":"Factors limiting depth of a maximal inspiration in human subjects","volume":"18","author":"Mead","year":"1963","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jcf.2026.07.010_bib0017","first-page":"419","article-title":"Limiting factors of expiration in normal subjects","volume":"4","author":"Slagter","year":"1955","journal-title":"Acta Physiol Pharmacol Neerl"},{"key":"10.1016\/j.jcf.2026.07.010_bib0018","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cct.2017.11.012","article-title":"Study design considerations for the standardized treatment of pulmonary exacerbations 2 (STOP2): a trial to compare intravenous antibiotic treatment durations in CF","volume":"64","author":"Heltshe","year":"2018","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jcf.2026.07.010_bib0019","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcf.2009.04.003","article-title":"Patient\u2013reported respiratory symptoms in cystic fibrosis","volume":"8","author":"Goss","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.07.010_bib0020","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jcf.2019.05.009","article-title":"Correspondence between lung function and symptom measures from the cystic fibrosis respiratory symptom diary\u2013chronic respiratory infection symptom score (CFRSD\u2013CRISS)","volume":"18","author":"Gold","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.07.010_bib0021","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi\u2013ethnic reference values for spirometry for the 3\u201395\u2013yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.07.010_bib0022","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcf.2025.12.007","article-title":"STOP2 Investigators. Correlates of FEV(1) deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomes","volume":"25","author":"McElvaney","year":"2026","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.07.010_bib0023","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jcf.2026.07.010_bib0024","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev.publhealth.21.1.121","article-title":"Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches","volume":"21","author":"Little","year":"2000","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jcf.2026.07.010_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.jcf.2026.07.010_bib0026","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcf.2021.12.003","article-title":"C\u2013reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response","volume":"21","author":"VanDevanter","year":"2022","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326016851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326016851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:26:57Z","timestamp":1786879617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326016851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S1569199326016851"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.07.010","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Forced vital capacity in pulmonary exacerbations of cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}